Cargando…

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice

Levosimendan is a calcium sensitizer and adenosine triphosphate–dependent potassium channel opener, which exerts sustained hemodynamic, symptomatic, and organ-protective effects. It is registered for the treatment of acute heart failure, and when inotropic support is considered appropriate. In the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guarracino, Fabio, Heringlake, Matthias, Cholley, Bernard, Bettex, Dominique, Bouchez, Stefaan, Lomivorotov, Vladimir V., Rajek, Angela, Kivikko, Matti, Pollesello, Piero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2018
Materias:	Drugs in the Pipeline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768218/ https://www.ncbi.nlm.nih.gov/pubmed/29076887 http://dx.doi.org/10.1097/FJC.0000000000000551

Ejemplares similares

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014)

Targeting β(3)-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade
por: Cannavo, Alessandro, et al.
Publicado: (2017)

FDA review times for new drugs in ophthalmology
por: Carpenter, Michelle A., et al.
Publicado: (2020)

Five variables that rule your life – Home mortgage and biostatistical power
por: Novack, Gary D.
Publicado: (2020)

Repurposing medications
por: Novack, Gary D.
Publicado: (2021)

What is an adequate and well controlled study?
por: Novack, Gary D.
Publicado: (2021)

Expedited regulatory product approval in the time of COVID-19
por: Novack, Gary D.
Publicado: (2022)

Compounded medications for ocular surface disease
por: Lee, Edward H., et al.
Publicado: (2021)

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure
por: Wohlford, George F., et al.
Publicado: (2021)

Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)
por: Caruba, Thibaut, et al.
Publicado: (2016)

Special features of RAD Sequencing data: implications for genotyping
por: Davey, John W, et al.
Publicado: (2013)

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
por: Bouchez, S., et al.
Publicado: (2018)

Levosimendan: current data, clinical use and future development
por: Nieminen, M S, et al.
Publicado: (2013)

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)

Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?
por: Burashnikov, Alexander
Publicado: (2020)

Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry
por: Dobarro, David, et al.
Publicado: (2023)

Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety
por: Girardis, M., et al.
Publicado: (2022)

Levosimendan‐induced venodilation is mediated by opening of potassium channels
por: Burkhoff, Daniel, et al.
Publicado: (2021)

EST Pipeline System: Detailed and Automated EST Data Processing and Mining
por: Xu, Hao, et al.
Publicado: (2003)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Renal Effects of Levosimendan: A Consensus Report
por: Yilmaz, Mehmet B., et al.
Publicado: (2013)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta‐analysis of randomized trials
por: Silvetti, Simona, et al.
Publicado: (2017)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

The JCSG high-throughput structural biology pipeline
por: Elsliger, Marc-André, et al.
Publicado: (2010)

TOPSAN: use of a collaborative environment for annotating, analyzing and disseminating data on JCSG and PSI structures
por: Krishna, S. Sri, et al.
Publicado: (2010)

Interaction between renal function and the effect of levosimendan on long-term mortality of patients with low-output heart failure
por: Cleland, J, et al.
Publicado: (2003)

Model standard : L'éléphant, le tigre, le pingouin et la licorne
Publicado: (1995)

Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay
por: Grossini, Elena, et al.
Publicado: (2015)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study
por: Kivikko, Matti, et al.
Publicado: (2015)

Unbearable Pruritus After Withdrawal of (Levo)cetirizine
por: Ekhart, Corine, et al.
Publicado: (2016)

Measurements of prompt gamma-rays from fast-neutron induced fission with the LICORNE directional neutron source
por: Wilson, J N, et al.
Publicado: (2014)

Efficacy of levosimendan infusion in patients undergoing a left ventricular assist device implant in a propensity score matched analysis of the EUROMACS registry—the Euro LEVO-LVAD study
por: Abdelshafy, Mahmoud, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9adrijc46csci52j1rdlh1evb0